Ma Somsouk, Rachel Kornfield, Eric Vittinghoff, John M. Inadomi, Scott W. Biggins – 28 October 2010 – Donor livers are offered to patients with the highest risk of death. How ascites could inform risk models to reduce liver transplant wait‐list mortality is unclear. All adult candidates for primary liver transplantation for cirrhosis without exception points who were registered with the Organ Procurement and Transplantation Network from 2005 to 2007 composed our study cohort.

See Ching Chan, Chung Mau Lo, Sheung Tat Fan – 28 October 2010

Steven Van Laecke, Federico Desideri, Anja Geerts, Hans Van Vlierberghe, Frederik Berrevoet, Xavier Rogiers, Roberto Troisi, Bernard de Hemptinne, Raymond Vanholder, Isabelle Colle – 28 October 2010 – New‐onset diabetes after transplantation (NODAT) is a frequent complication after liver transplantation and has a negative impact on both patient and graft survival.

Norman M. Kneteman, Toshiyasu Kawahara – 28 October 2010

Mahmoud Abu‐Amara, Shiyu Yang, Niteen Tapuria, Barry J. Fuller, Brian R. Davidson, Alexander M. Seifalian – 28 October 2010

Ricky Harminder Bhogal, Stuart M. Curbishley, Christopher J. Weston, David H. Adams, Simon C. Afford – 28 October 2010 – Increasing evidence shows that reactive oxygen species (ROS) may be critical mediators of liver damage during the relative hypoxia of ischemia/reperfusion injury (IRI) associated with transplant surgery or of the tissue microenvironment created as a result of chronic hepatic inflammation or infection. Much work has been focused on Kupffer cells or liver resident macrophages with respect to the generation of ROS during IRI.

Andrew J. Portal, Mark J. W. McPhail, Matthew Bruce, Iona Coltart, Andrew Slack, Roy Sherwood, Nigel D. Heaton, Debbie Shawcross, Julia A. Wendon, Michael A. Heneghan – 28 October 2010 – Postoperative acute kidney injury (AKI) increases morbidity and mortality after liver transplantation (LT). Novel methods of assessing AKI including cystatin C (CyC) and neutrophil gelatinase–associated lipocalin (NGAL) have been identified as potential markers of AKI.

Celina M. Yong, Madan Sharma, Victor Ochoa, Freddy Abnousi, John Roberts, Nathan M. Bass, Claus U. Niemann, Stephen Shiboski, Megha Prasad, Mehdi Tavakol, Thomas A. Ports, Gabriel Gregoratos, Yerem Yeghiazarians, Andrew J. Boyle – 28 October 2010 – The optimal preoperative cardiac evaluation strategy for patients with end‐stage liver disease (ESLD) undergoing liver transplantation remains unknown. Patients are frequently referred for cardiac catheterization, but the effects of coronary artery disease (CAD) on posttransplant mortality are also unknown.

Hung‐Tien Kuo, Christine Lau, Marcelo Santos Sampaio, Suphamai Bunnapradist – 28 October 2010 – Our objectives are to examine the incidence of new‐onset diabetes mellitus after transplant (NODAT) and to identify its risk factors in pediatric liver transplant recipients using the Organ Procurement and Transplant Network/United Network for Organ Sharing database. Between July 2004 and December 2008, a total of 1214 children (2‐20 years old) received their first liver transplant alone, and had at least 1 follow‐up report of posttransplant diabetic status.

Jeremy Durack, Nathan Bass, David Teitel, Robert Kerlan, John Roberts – 28 October 2010